Here's what Houston hospitals ranked as best in the nation this year

best of the rest

U.S. News & World Report has released its annual and much-heralded list of Best Hospitals in the nation. Photo courtesy

A prestigious, annual national report has verified what Houstonians already know: Our Medical Center boasts the best adult and children’s hospital in Texas and the best cancer center in America.

U.S. News & World Report released its 2022-23 Best Hospitals list, which names The University of Texas MD Anderson Cancer Center No. 1 in the nation for cancer care. For those keeping track, MD Anderson has been considered in the top two cancer hospitals in the U.S. since the U.S. News launched the survey in 1990.

While securing the top rank for cancer care, MD Anderson also scored high national ranks for specialty treatments: urology (No. 5) and diabetes and endocrinology (No. 13). The center continues to maintain its “High Performing” rating on the U.S. News list for colon cancer and lung cancer. It also received “High Performing” ratings for the three newly added adult procedures and conditions: ovarian cancer, prostate cancer, and uterine cancer, per a press release.

“We are proud to be ranked as the nation’s leader in cancer care,” said Peter WT Pisters, M.D., president of MD Anderson, in a statement. “This ongoing recognition is thanks to the incredible MD Anderson community, including our faculty, employees, trainees, students, donors and advocates, who advance our science and our mission and who serve our patients by enabling us to provide the best care possible.”

Rankings for the annual U.S. News study are based on scores in patient care, patient safety, outcomes, nursing, advanced technology, and reputation.

Houston leads medicine in Texas
The tagline for Houston Methodist Hospital systems — “leading medicine” — is quite fitting here in Texas. The hospital comes in at No. 15 nationally (marking the sixth time it has been recognized in the report’s Honor Roll) and No. 1 in Texas for the 11th year in a row. Locally, Houston Methodist Sugar Land ranks No. 5 in Houston and No. in Texas, a press release notes.

Notably, U.S. News has ranked Houston Methodist Hospital in at least one specialty for the past 30 years. This year, Houston Methodist Hospital ranks in 10 specialties, the most of any hospital in the state, according to the report. Two of these ranked specialties appear in the list’s top 10 (diabetes and endocrinology at No. 9; gastroenterology/GI surgery at No. 8), while six are ranked in the top 20.

“This is a tremendous achievement for our physicians and employees who dedicate themselves every day to our patients – especially as we continue to provide the highest quality care during these trying times in health care,” said Marc Boom, M.D., president and CEO of Houston Methodist, in a statement. “Our mission to provide unparalleled care is for our patients, who are the reason we need to be one of the best hospital systems in the country.”

Texas Children’s tops Texas and Southwest
Yet another Houston hospital scored extremely well nationally in the list. Texas Children’s Hospital ranks No. 2 overall in the Best Children’s Hospitals ranking. The beloved children’s center also remains top in Texas and the Southwest, and at No. 1 in heart treatment for the sixth year in a row. No other pediatric hospital in Texas has achieved an overall ranking as high as Texas Children’s has in the past 14 years, a Texas Children’s release notes.

“We are beyond thrilled with the newest U.S. News & World Report rankings that place Texas Children’s Hospital second in the United States and first in the state of Texas,” said Mark A. Wallace, president and CEO, in a statement. “Consistent collaboration, newfound discoveries and extraordinary patient care is what has brought us to where we are today. I am incredibly proud of this remarkable team and everything we’ve accomplished together — and our promise to every family is that we are just getting started.”

Texas’ best mental health care is here
Also boasting top honors in the state — and No. 10 nationally — is the Menninger Clinic. The acclaimed facility tied for tenth place on U.S. News’ list of best psychiatric hospitals, making it the all-out best in Texas.

Of note, Menninger has been named a top-10 psychiatry hospital in the U.S. for 32 consecutive years, the hospital points out. “With the growing need for mental health care, we are grateful for the trust that psychiatrists have had in referring their clients to The Menninger Clinic for comprehensive diagnosis and treatment,” said president and CEO Armando E. Colombo in a statement.

Elsewhere in Texas
Dallas-Fort Worth is home to the No. 2 hospital in Texas, per U.S. News. UT Southwestern Medical Center in Dallas also ranked especially well nationally in urology (No. 11), cardiology and heart surgery (No. 14), diabetes and endocrinology (No. 18), pulmonology and lung surgery, (No. 21), and cancer (No. 25).

Not far down the list is Baylor University Medical Center in Dallas, which ranked No. 4 in Texas. One Baylor department ranked nationally: gastroenterology and GI surgery department, No. 34.

Meanwhile, Austin’s St. David’s Medical Center ranked No. 8 in Texas. Austinites in need of post-procedure work and physical therapy should note that the hospital’s rehabilitation department ranked nationally, coming in at No. 37 overall.

------

This article originally ran on CultureMap.

From Your Site Articles
Through a $4 million grant, the city of Houston will be able to provide mental health treatment to at-risk students. Educational First Steps/Facebook

City of Houston and local health care organizations receive $4M to treat mental health in students

Help granted

The city of Houston just received a major opportunity to help grow access to mental health treatment in children.

Thanks to a four-year $4 million grant from the United States Substance Abuse and Mental Health Services Administration, the city and its partner, Baylor College of Medicine, are launching the Be-Well Be-Connected program that provides at-risk students age six to 17 years old with mental health treatment.

The program will be led by Dr. Laurel Williams, associate professor of psychiatry at Baylor, division head for child and adolescent psychiatry and chief of psychiatry at Texas Children's Hospital. The treatment will include cognitive behavioral intervention for students with bipolar disorder and first episode psychosis, according to the release. The services will be provided in the child's home, which will ensure compliance.

"We do not have many places in Houston that have this capability to provide this level of intensity of services," Williams says in the release. "Having in-home therapy can allow the young person to stay engaged in their community and in their schools, which can promote wellness and reduction in symptoms burden more quickly."

Other Houston health centers, including Texas Children's Hospital, Harris Health System, Menninger Clinic, Harris Center, Veteran's Mental Health Care Line, Legacy Community Health Services, and DePelchin's Children's Center, will be involved with the program and the Mayor's Office of Education is the program manager of the grant.

"I created the Office of Education to support school districts in Houston because they are doing the essential work of guaranteeing that our next generation of adults is educated and ready for the future," says Mayor Sylvester Turner in the release. "The grant validates our efforts and more importantly will provide care on the frontlines of a key health issue involving young people."

Five independent school districts will also receive first level screening services and telemedical care. Families of the students receiving care will also receive support from the newly developed Texas State Child Mental Health Consortium.

"Houston and our surrounding area is primed to really take children's mental health care to the next needed level," says Williams in the release. "This SAMHSA grant opportunity coupled with the State Consortium will allow better coordination amongst services and an overall increase in available services — services that are desperately needed."

Houston Methodist Hospital once again lands on U.S. News & World Report's "Honor Roll." Courtesy of Methodist Hospital/Facebook

2 Houston hospitals honored among America's best in prestigious report

What the Doctor Ordered

Houston's Medical Center is often described as the epicenter of innovation and treatment in the U.S. — as well as the site of Nobel Prize-winning work. Now, a new report offers more bragging rights for the beloved center, as two of its hospitals have landed on a coveted list of the best facilities in the nation.

U.S. News & World Report has released its 2019-2020 list of best hospitals, citing Houston Methodist Hospital and The Menninger Clinic among the top in America.

The publication named Houston Methodist Hospital to its Honor Roll, a list of the top 20 hospitals in the country. Methodist tied for No. 20 with Yale New Haven Hospital in Connecticut, Mayo Clinic-Phoenix, and Hospitals of the University of Pennsylvania-Penn Presbyterian in Philadelphia.

To determine the Honor Roll, U.S. News ranks hospital performance in 16 areas of complex specialty care and rates hospitals in nine bellwether procedures and conditions, such as heart bypass, hip and knee replacement, heart failure, and lung cancer surgery, the publication notes.

This is the third time Methodist has secured the Honor Roll and the eighth year in a row it has been named the No. 1 hospital in Texas. Methodist also ranked No. 1 in the Gulf Coast region and was awarded national rankings in nine adult specialties and recognized as "high performing" for nine adult procedures and conditions.

Meanwhile, in the nationwide survey, The Menninger Clinic ranked No. 5 overall among Best Hospitals for Psychiatry. The institution, which offers treatment services for psychiatric disorders and substance abuse issues, has been ranked by U.S. News for 30 consecutive years, according to a release.

The report distinguishes the best hospitals for patients experiencing difficult-to-treat psychiatric disorders and is based on survey responses from 2017 to 2019 from physicians nationwide who are board certified in psychiatry, according to the publication.

During the three-year survey period, Menninger treated patients from all 50 states and 18 countries through five specialty inpatient programs, says a release. The hospital assists patients ranging from adolescents to adult professionals and hosts a popular annual luncheon featuring a celebrity keynote speaker who has dealt with mental wellness issues.

------

This story originally appeared on CultureMap.com.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Property Showcase

Houston engineers develop breakthrough device to advance spinal cord treatment

future of health

A team of Rice University engineers has developed an implantable probe over a hundred times smaller than the width of a hair that aims to help develop better treatments for spinal cord disease and injury.

Detailed in a recent study published in Cell Reports, the probe or sensor, known as spinalNET, is used to explore how neurons in the spinal cord process sensation and control movement, according to a statement from Rice. The research was supported by the National Institutes of Health, Rice, the California-based Salk Institute for Biological Studies, and the philanthropic Mary K. Chapman Foundation based in Oklahoma.

The soft and flexible sensor was used to record neuronal activity in freely moving mice with high resolution for multiple days. Historically, tracking this level of activity has been difficult for researchers because the spinal cord and its neurons move so much during normal activity, according to the team.

“We developed a tiny sensor, spinalNET, that records the electrical activity of spinal neurons as the subject performs normal activity without any restraint,” Yu Wu, a research scientist at Rice and lead author of the study said in a statement. “Being able to extract such knowledge is a first but important step to develop cures for millions of people suffering from spinal cord diseases.”

The team says that before now the spinal cord has been considered a "black box." But the device has already helped the team uncover new findings about the body's rhythmic motor patterns, which drive walking, breathing and chewing.

Lan Luan (from left), Yu Wu, and Chong Xie are working on the breakthrough device. Photo by Jeff Fitlow/Rice University

"Some (spinal neurons) are strongly correlated with leg movement, but surprisingly, a lot of neurons have no obvious correlation with movement,” Wu said in the statement. “This indicates that the spinal circuit controlling rhythmic movement is more complicated than we thought.”

The team said they hope to explore these findings further and aim to use the technology for additional medical purposes.

“In addition to scientific insight, we believe that as the technology evolves, it has great potential as a medical device for people with spinal cord neurological disorders and injury,” Lan Luan, an associate professor of electrical and computer engineering at Rice and a corresponding author on the study, added in the statement.

Rice researchers have developed several implantable, minimally invasive devices to address health and mental health issues.

In the spring, the university announced that the United States Department of Defense had awarded a four-year, $7.8 million grant to the Texas Heart Institute and a Rice team led by co-investigator Yaxin Wang to continue to break ground on a novel left ventricular assist device (LVAD) that could be an alternative to current devices that prevent heart transplantation.

That same month, the university shared news that Professor Jacob Robinson had published findings on minimally invasive bioelectronics for treating psychiatric conditions. The 9-millimeter device can deliver precise and programmable stimulation to the brain to help treat depression, obsessive-compulsive disorder and post-traumatic stress disorder.

Houston clean hydrogen startup to pilot tech with O&G co.

stay gold

Gold H2, a Houston-based producer of clean hydrogen, is teaming up with a major U.S.-based oil and gas company as the first step in launching a 12-month series of pilot projects.

The tentative agreement with the unnamed oil and gas company kicks off the availability of the startup’s Black 2 Gold microbial technology. The technology underpins the startup’s biotech process for converting crude oil into proprietary Gold Hydrogen.

The cleantech startup plans to sign up several oil and gas companies for the pilot program. Gold H2 says it’s been in discussions with companies in North America, Latin America, India, Eastern Europe and the Middle East.

The pilot program is aimed at demonstrating how Gold H2’s technology can transform old oil wells into hydrogen-generating assets. Gold H2, a spinout of Houston-based biotech company Cemvita, says the technology is capable of producing hydrogen that’s cheaper and cleaner than ever before.

“This business model will reshape the traditional oil and gas industry landscape by further accelerating the clean energy transition and creating new economic opportunities in areas that were previously dismissed as unviable,” Gold H2 says in a news release.

The start of the Black 2 Gold demonstrations follows the recent hiring of oil and gas industry veteran Prabhdeep Singh Sekhon as CEO.

“With the proliferation of AI, growth of data centers, and a national boom in industrial manufacturing underway, affordable … carbon-free energy is more paramount than ever,” says Rayyan Islam, co-founder and general partner at venture capital firm 8090 Industries, an investor in Gold H2. “We’re investing in Gold H2, as we know they’ll play a pivotal role in unleashing a new dawn for energy abundance in partnership with the oil industry.”

------

This article originally ran on EnergyCapital.

3 Houston innovators to know this week

who's who

Editor's note: Every week, I introduce you to a handful of Houston innovators to know recently making headlines with news of innovative technology, investment activity, and more. This week's batch includes an e-commerce startup founder, an industrial biologist, and a cellular scientist.

Omair Tariq, co-founder and CEO of Cart.com

Omair Tariq of Cart.com joins the Houston Innovators Podcast to share his confidence in Houston as the right place to scale his unicorn. Photo via Cart.com

Houston-based Cart.com, which operates a multichannel commerce platform, has secured $105 million in debt refinancing from investment manager BlackRock.

The debt refinancing follows a recent $25 million series C extension round, bringing Cart.com’s series C total to $85 million. The scaleup’s valuation now stands at $1.2 billion, making it one of the few $1 billion-plus “unicorns” in the Houston area.

Cart.com was co-founded by CEO Omair Tariq in October 2020. Read more.

Nádia Skorupa Parachin, vice president of industrial biotechnology at Cemvita

Nádia Skorupa Parachin joined Cemvita as vice president of industrial biotechnology. Photo courtesy of Cemvita

Houston-based biotech company Cemvita recently tapped two executives to help commercialize its sustainable fuel made from carbon waste.

Nádia Skorupa Parachin came aboard as vice president of industrial biotechnology, and Phil Garcia was promoted to vice president of commercialization.

Parachin most recently oversaw several projects at Boston-based biotech company Ginkjo Bioworks. She previously co-founded Brazilian biotech startup Integra Bioprocessos. Read more.

Han Xiao, associate professor of chemistry at Rice University

The funds were awarded to Han Xiao, a chemist at Rice University.

A Rice University chemist has landed a $2 million grant from the National Institute of Health for his work that aims to reprogram the genetic code and explore the role certain cells play in causing diseases like cancer and neurological disorders.

The funds were awarded to Han Xiao, the Norman Hackerman-Welch Young Investigator, associate professor of chemistry, from the NIH's Maximizing Investigators’ Research Award (MIRA) program, which supports medically focused laboratories. Xiao will use the five-year grant to advance his work on noncanonical amino acids.

“This innovative approach could revolutionize how we understand and control cellular functions,” Xiao said in the statement. Read more.

View All Listings